Member Info for Livedataaccount

I really can feel it on my bones Alan is going to move to America, in search of the MTD. Make od that what you will

Its a similar comment to 'the market is as thick as mince'.

Good news

#voteED

50% chance

I have been contemplating for a while whether Alan will relocate to America.

Americans coming online

How can you be sure Alans paradigm is the same as yours?

Alan is going to need sometbing to do when a major gobbles up the therapeutics side of the business.

Im out at 4 quid

Good advice

I would also email Alan (Alastair) directly.

Good post, Hurst

Looking good

Hopefully they will turn up en masse today

Good news

#votehillary

Smallish amount of shares. But not ideal having the constant drip sell of shares.

First line treatment

Ie. The go to drug

From yesterdays RNS

I dont think many have picked up the fact AVA6000 is going to be trialled as a First Line Treatment for STS patients in a seperate study.

'Therefore, in parallel with the completion of cohort 7, the Company intends to begin a short study to explore more frequent dosing (fortnightly) of AVA6000 as a first line treatment in patients with soft tissue sarcoma. The study is expected to begin in Q4 2023 subject to receipt of approval of a protocol amendment from the US Food & Drug Administration (FDA).'

Good listen